RTF/RTU Vials Market to Witness 14.5% CAGR Growth by 2030

The global ready-to-fill/ready-to-use (RTF/RTU) vials market is witnessing significant growth due to pharmaceutical companies' increasing emphasis on enhancing operational efficiency, the rising popularity of injectable drugs, expanding production of vials, escalating healthcare expenditure, and the overall growth of the pharmaceutical sector. Consequently, the revenue from these products is projected to grow at a 14.5% CAGR between 2021 and 2030, reaching $1,183.4 million by the end of the forecast period.

The COVID-19 pandemic has further accelerated the demand for RTF/RTU vials, driven by the need for vaccine distribution. Moreover, heightened R&D and clinical trials during the pandemic encouraged vial manufacturers to scale up production. Robust packaging is essential for the effective distribution of vaccines, leading to increased demand for vials.

Preference for Nest and Tub Packaging Set to Continue

Based on packaging type, the RTF/RTU vials market is segmented into tray and nest & tub. Among these, nest & tub packaging holds the largest share and will continue to dominate throughout the forecast period. This packaging style has been widely adopted in the pharmaceutical industry due to its early introduction and efficient nest-like arrangement, which reduces the chances of vial damage, enhancing end-user acceptance.

The market is categorized into liquid and lyophilized products based on the type of filling. Liquid products led the market in 2020 and are expected to maintain the highest CAGR till 2030. Injectable drugs are primarily in liquid form, while the lyophilization process is more complex and costly, requiring significant equipment and space.

Download free report sample at: https://www.psmarketresearch.com/market-analysis/rtf-rtu-vials-market-trends/report-sample

Europe to Lead the Market Through 2030

Europe is expected to remain the largest market for RTF/RTU vials, driven by increasing production output, a thriving pharmaceutical industry, and rising healthcare expenditure. Additionally, the region is home to numerous key players, such as SCHOTT AG, Stevanato Group, Gerresheimer AG, and SGD S.A., who are heavily invested in meeting the growing demand for COVID-19 vaccines.

Facility Expansion Driving Market Growth

To enhance their revenue, companies in the RTF/RTU vials market are expanding their production facilities. For instance, SCHOTT AG established a new pharmaceutical tubing factory in Zhejiang Province, China, in December 2020. This facility aims to produce 20,000 tons of FIOLAX borosilicate glass tubing for vials, cartridges, syringes, and ampoules, with a gradual increase in production.

Similarly, in July 2020, Gerresheimer India announced plans to triple its tubular glass production and double the output of molded vials by the end of 2020. This expansion allowed the company to increase its production of multi-dose borosilicate vials from 150 million units to 300 million by the end of 2021.

Prominent companies in the global RTF/RTU vials market include SCHOTT AG, SGD S.A., Gerresheimer AG, Stevanato Group, Nipro Corporation, China Lemon Trading Co. Ltd., DWK Life Sciences GmbH, and Ningbo Zhengli Pharmaceutical Packaging Co. Ltd.

About P&S Intelligence

 

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

 

Contact:
Chandra Mohan
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com